Cardiovascular disease risk and associated factors among people with hypertension in the West Bank, Palestine - Report - MDSpire

Cardiovascular disease risk and associated factors among people with hypertension in the West Bank, Palestine

  • By

  • Alhareth M. Amro

  • Salahaldeen Deeb

  • Elias Amarneh

  • Alfarouq Alboom

  • Zein Abuhantash

  • Mirna Mustafa

  • Batool Bader

  • Areej A. Milhem

  • Abdalrahman M. Alfaour

  • Bajis Amro

  • June 10, 2026

  • 0 min

Share

Clinical Report: Assessing Cardiovascular Disease Risk Factors in Hypertensive Individuals

Overview

This study evaluates cardiovascular disease risk factors among hypertensive individuals in the West Bank, revealing that over half of the participants have moderate-to-high predicted 10-year cardiovascular disease risk. Key determinants include advancing age, diabetes mellitus, and family history of hypertension.

Background

Hypertension significantly contributes to cardiovascular disease (CVD) morbidity and mortality, particularly in low- and middle-income countries. Understanding the absolute cardiovascular risk in hypertensive populations is crucial for developing effective prevention strategies. This study addresses the gap in knowledge regarding cardiovascular risk factors among hypertensive individuals in Palestine.

Data Highlights

CharacteristicValue
Participants401
Mean Age59.2 ± 11.3 years
Female Participants63.1%
Moderate-to-High Risk50.4%
High Risk24.7%

Key Findings

  • 50.4% of participants had moderate-to-high predicted 10-year cardiovascular disease risk.
  • 24.7% were classified as high risk for cardiovascular disease.
  • Each additional year of age increased the odds of cardiovascular disease by approximately 4% (aOR ≈ 1.04, p < 0.001).
  • Diabetes mellitus was associated with high predicted cardiovascular risk (aOR range ≈ 1.8–2.4, p ≤ 0.01).
  • A positive family history of hypertension was linked to increased cardiovascular disease risk (aOR ≈ 1.9, p < 0.01).
  • Marital status showed a protective association with cardiovascular disease risk (aOR ≈ 0.5, p < 0.01).

Clinical Implications

The findings underscore the importance of routine cardiovascular risk assessment in hypertensive patients, particularly focusing on age and diabetes management. Healthcare providers should consider integrating comprehensive cardiometabolic management strategies to mitigate cardiovascular risk in this population.

Conclusion

Hypertensive individuals in the West Bank exhibit significant cardiovascular disease risk, primarily influenced by age and diabetes. Addressing these risk factors through targeted interventions is essential for improving cardiovascular health outcomes.

Related Resources & Content

  1. Open Forum Infectious Diseases, 2023 -- Assessment of Cardiovascular Risk Factors in Adults With HIV Acquired at Birth
  2. European Journal of Preventive Cardiology, 2023 -- Tailored Physical Activity Guidelines Based on Cardiovascular Disease Risk Assessment: Findings from a Cohort Study
  3. The Journal of Clinical Endocrinology & Metabolism, 2023 -- Association of Arterial Stiffness with Long-term Major Adverse Cardiovascular Events in Individuals Diagnosed with Primary Aldosteronism
  4. European Journal of Preventive Cardiology, 2023 -- Establishing and validating a diagnostic benchmark for central blood pressure in evaluating cardiovascular risk factors
  5. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension | European Heart Journal, 2024
  6. A Randomized Trial of Intensive versus Standard Blood-Pressure Control | New England Journal of Medicine, 2015
  7. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions, 2020
  8. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension | European Heart Journal | Oxford Academic
  9. A Randomized Trial of Intensive versus Standard Blood-Pressure Control | New England Journal of Medicine
  10. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions - PMC

Original Source(s)

Related Content